Dr. Lambros Stamatakis

What to do when prostate cancer biopsy/PSA test results conflict

Ross Krasnow, MD, Urologic Oncologist, Lambros Stamatakis, MD, Director, Urologic Oncology September 28, 2017

Prostate cancer can be challenging to detect. Our screening and diagnostic tools—prostate-specific antigen (PSA) testing and transrectal ultrasound-guided (TRUS) prostate…

Treating bladder cancer: What patients need to know

Lambros Stamatakis, MD, Director, Urologic Oncology November 14, 2017

While bladder cancer doesn’t get as much press as colon or lung cancer, it’s the fourth-most common type of cancer…

Immunotherapy: The future course of bladder cancer care

Lambros Stamatakis, MD, Director, Urologic Oncology December 14, 2017

In the 1990s, the Food and Drug Administration (FDA) approved a treatment for bladder cancer called Bacillus Calmette-Guerin therapy, or…